Liberty Posada
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Ophthalmology top 2%
- Ocular Oncology and Treatments
Papers in
-
- Ocular Oncology and Treatments 2
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Roland L. Bassett (3 shared papers)Patrick Hwu (3 shared papers)Sapna Pradyuman Patel (3 shared papers)Dan S. Gombos (2 shared papers)Michael Shephard (1 shared paper)Brett W. Carter (1 shared paper)Stephen K. Gruschkus (1 shared paper)Meredith S. Pelster (1 shared paper)
- Journals
- Melanoma Research (1 paper)Journal of Clinical Oncology (1 paper)Nature Medicine (1 paper)Cancers (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Liberty Posada
4 papers receiving 942 citations
Liberty Posada's Hit Papers
Peers
Comparison fields: 5 of 46
- Oncology 612
- Ophthalmology 193
- Immunology 354
- Cancer Research 49
- Biophysics 17
Countries citing papers authored by Liberty Posada
This map shows the geographic impact of Liberty Posada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liberty Posada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liberty Posada more than expected).
Fields of papers citing papers by Liberty Posada
This network shows the impact of papers produced by Liberty Posada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liberty Posada. The network helps show where Liberty Posada may publish in the future.
Co-authors
The 14 scholars most cited alongside Liberty Posada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma Hit paper breakdown → | 2018 | 679 |
| 2 | Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study Hit paper breakdown → | 2020 | 232 |
| 3 | 2019 | 25 | |
| 4 | 2016 | 16 |
About Liberty Posada
Liberty Posada is a scholar working on Ophthalmology, Immunology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 4 papers that have together received 952 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Ocular Oncology and Treatments (2 papers), Glioma Diagnosis and Treatment (1 paper), CAR-T cell therapy research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Brain Metastases and Treatment (1 paper), Melanoma and MAPK Pathways (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Oncology (612 citations), Ophthalmology (193 citations), Immunology (354 citations), Cancer Research (49 citations) and Biophysics (17 citations). Liberty Posada has collaborated with scholars based in United States and Australia. Frequent co-authors include Roland L. Bassett, Patrick Hwu, Sapna Pradyuman Patel, Dan S. Gombos, Michael Shephard, Brett W. Carter, Stephen K. Gruschkus, Meredith S. Pelster, Adi Diab and Agop Y. Bedikian. Their work appears in journals such as Melanoma Research, Journal of Clinical Oncology, Nature Medicine and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.